Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Tofacitinib may help treat hair loss in children with alopecia areata.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Baricitinib is the most effective treatment for alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A blood pressure drug, diltiazem, may also help treat influenza.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Tinea capitis, a scalp fungal infection in children, is best treated with newer antifungal agents for shorter periods.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.